Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Lab technician Christophe KIKWABANTU at the laboratory of Walikale Hospital, North Kivu, February 12, 2017. Photograph by Gwenn Dubourthoumieu
Press release
Press release |
02 February 2017
Research and development

European public health advocates demand greater public returns from European Commission’s Research and Development Programme, Horizon 2020

3 min
Pooja Iyer, MSF counselor, providing counseling to Hanif, an XDR-TB patient, in the MSF clinic in Mumbai. India 2016 Photograph by Atul Loke/Panos Pictures
Press release
Press release |
30 January 2017
Tuberculosis
India

Health groups call on Government of India to urgently make lifesaving TB drug available

6 min
Medical staff work in the ambulatory ward at the National Centre for Tuberculosis and Lung Disease in Georgia’s capital, Tbilisi. Patient Goderdzi Rajabishvili (left) recovers from his morning infusion of imipenem, an antibiotic drug used for the treatment of MDR-TB. Photograph by Daro Sulakauri Photograph by Daro Sulakauri
Press release
Press release |
25 January 2017

Public Health Groups Welcome Johns Hopkins University and Medicines Patent Pool Agreement

6 min
Nischaya, an XDR-TB patient, looking at her TB medication at the MSF clinic in Mumbai. Photograph by Atul Loke Photograph by Atul Loke
Press release
Press release |
20 January 2017
Tuberculosis

Pioneering new MSF-run clinical trial for drug-resistant TB treatment starts

5 min
MSF staff hold an informative meeting on Chagas treatment in the community of Kochapata, Bolivia. Photograph by Juan Renau Photograph by Juan Renau
Press release
Press release |
20 December 2016
Tropical & neglected diseases

Bolivia: Doctors Without Borders ends Chagas operations, urges Ministry of Health to take over comprehensive care in rural areas

4 min
Press release |
08 December 2016

MSF Access Campaign names new Executive Director

2 min
Celumusa Hlatswako, an MSF mobile counselor, visits Winile, 39, XDR-TB patient & HIV-positive. They use sign language to communicate because Winile went deaf due to the side effects of the treatment. Matsapha airport, Manzini Region, Swaziland. Photograph by Alexis Huguet
Press release
Press release |
05 December 2016
Intellectual property and trade

RCEP trade deal negotiators must reject terms that would harm access to medicines

4 min
Kulsoom is 20 years old. She has just completed his treatment against hepatitis C and is now cured from the disease. Photograph by Sa'adia Khan
Press release
Press release |
14 November 2016
Intellectual property and trade

MSF responds to latest Access to Medicines Index rankings

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury